-
1 Comment
China NT Pharma Group Company Limited is currently in a long term downtrend where the price is trading 6.8% below its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.6.
China NT Pharma Group Company Limited's total revenue sank by 50.3% to $89M since the same quarter in the previous year.
Its net income has increased by 86.0% to $-83M since the same quarter in the previous year.
Finally, its free cash flow grew by 162.8% to $14M since the same quarter in the previous year.
Based on the above factors, China NT Pharma Group Company Limited gets an overall score of 3/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| ISIN | KYG2114L1059 |
| PE Ratio | None |
|---|---|
| Beta | -2.0 |
| Market Cap | 239M |
| Target Price | 1.3 |
| Dividend Yield | None |
China NT Pharma Group Company Limited, together with its subsidiaries, engages in the investment, research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China. It manufactures, sells, and trades in prescription medicines; offers products in the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products. The company also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Central, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 1011.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
